SCHEMBL12318248

SCHEMBL12318248

CN[C@H](C)c1ccc(O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 9/20 0.56
▸ ESR2 Q92731 8/20 0.56
▸ PDCD1 Q15116 1/20 0.56
▸ CD274 Q9NZQ7 1/20 0.56
▸ ALDH1A1 P00352 3/20 0.50
▸ TDP1 Q9NUW8 2/20 0.48
▸ CYP2C9 P11712 2/20 0.48
▸ THPO P40225 2/20 0.48
▸ BLM P54132 2/20 0.48
▸ KDM4E B2RXH2 2/20 0.48
▸ HIF1A Q16665 2/20 0.48
▸ HTR1A P08908 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ NMUR2 Q9GZQ4 1/20 0.48
▸ TAAR1 Q96RJ0 1/20 0.48
▸ LMNA P02545 2/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ ALOX15 P16050 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18551584 1.00 ESR1 (0.56) ESR1ESR2PDCD1CD274ALDH1A1
SCHEMBL9912163 1.00 ESR1 (0.56) ESR1ESR2PDCD1CD274ALDH1A1
SCHEMBL5955203 0.80 ESR1 (0.56) ESR1ESR2PDCD1CD274ALDH1A1
SCHEMBL2669165 0.79 ALDH1A1 (0.54) ALDH1A1CYP2C9KDM4EHIF1ASMN1; SMN2
SCHEMBL14281851 0.78 ESR1 (0.54) ESR1ESR2PDCD1CD274ALDH1A1
SCHEMBL8284259 0.77 ALDH1A1 (0.52) ALDH1A1TDP1KDM4EHTR1ASMN1; SMN2
SCHEMBL8285887 0.77 ALDH1A1 (0.52) ALDH1A1TDP1KDM4EHTR1ASMN1; SMN2
SCHEMBL178538 0.77 ALDH1A1 (0.52) ALDH1A1TDP1KDM4EHTR1ASMN1; SMN2
SCHEMBL8285882 0.75 ALDH1A1 (0.50) ALDH1A1CYP2C9THPOCYP3A4ALOX15
SCHEMBL8284221 0.75 ALDH1A1 (0.50) ALDH1A1KDM4ESMN1; SMN2LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017030814-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF BROMODOMAIN-CONTAINING PROTEINS Arvinas, Inc. (US) 2017-02-23 — — WO disclosed
WO-2011103686-A1 CEPHALOSPORIN DERIVATIVES USEFUL AS β-LACTAMASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF VISWANATHA , SUNDARAMMA (CA) 2011-09-01 — — WO disclosed
Send feedback